Apart from the specificity-related problems, glucagon assays must be able to detect subtle changes in glucagon levels (as little as 1 pmol/l) to identify glucose-mediated suppression of secretion
empagliflozin added on to metformin monotherapy in uncontrolled type 2 diabetes: PIONEER 2
96374: Intravenous push, single or initial substance/drug 96375: Each additional sequential IV push of a new substance/drug 96376: Each additional IV push of the same drug, given at intervals of 30 minutes or more 96360 and 96361: These are for hydration therapy: 96360 Initial 31 minutes to 1 hour 96361 Each additional hour 90471: Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections)
VMI Sports L-Carnitine 1500 Heat Ingredients Each 1 Tbsp (15ml) serving provides the following: L-Carnitine Blend - 1500mg See above -- this blend similarly includes L-Carnitine, L-Carnitine Tartrate, and Acetyl-L-Carnitine
In the context of a restricted assay-format, in which implication of free LASSS can be excluded, the outcomes may provide critical insights towards understanding of an underlying LASSS-driven mechanism